tiprankstipranks
Trending News
More News >
Genex Pharmaceutical (GENX)
:GENX
US Market

Genex Pharmaceutical (GENX) Income Statement

Compare
12 Followers

Genex Pharmaceutical Income Statement

Last quarter (Q0 0), Genex Pharmaceutical's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Genex Pharmaceutical's net income was $-72.59K. See Genex Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 07Dec 06Dec 05Dec 04Sep 03
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 2.87M$ 2.22M$ 2.19M$ 2.07M$ -301.00
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ 3.38K
EBITDA
$ 718.27K$ 722.37K$ 980.43K$ 1.05M$ -48.87K
Operating Income
$ 662.13K$ 667.57K$ 920.59K$ 992.12K$ -52.26K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ 342.55K$ 618.96K$ 625.01K$ 1.01M$ -52.26K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Genex Pharmaceutical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis